BrightGene Bio Medical Technology C (688166) — Financial Flexibility Index
BrightGene Bio Medical Technology C (688166) has a Financial Flexibility Index of 0.04x as of June 2023. Free cash flow of CN¥94.76 Million (operating CF CN¥26.70 Million minus capex CN¥68.06 Million) represents 0% of total liabilities (CN¥2.46 Billion). Also explore how fast is BrightGene Bio Medical Technology C growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BrightGene Bio Medical Technology C Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for BrightGene Bio Medical Technology C across 9 annual periods. Check how strategically is BrightGene Bio Medical Technology C's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for BrightGene Bio Medical Technology C (2016–2024)
Year-by-year free cash flow to debt coverage for BrightGene Bio Medical Technology C. For the full company profile including market capitalisation, see BrightGene Bio Medical Technology C (688166) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.18x | CN¥502.76 Million | CN¥245.56 Million | CN¥2.73 Billion | ▼ -17.5% |
| 2023 | 0.22x | CN¥584.10 Million | CN¥194.77 Million | CN¥2.61 Billion | ▼ -47.9% |
| 2022 | 0.43x | CN¥1.04 Billion | CN¥311.26 Million | CN¥2.42 Billion | ▼ -51.5% |
| 2021 | 0.88x | CN¥1.09 Billion | CN¥176.08 Million | CN¥1.23 Billion | ▼ -31.6% |
| 2020 | 1.29x | CN¥510.70 Million | CN¥155.43 Million | CN¥395.23 Million | ▼ -7.3% |
| 2019 | 1.39x | CN¥150.87 Million | CN¥61.33 Million | CN¥108.21 Million | ▼ -16.6% |
| 2018 | 1.67x | CN¥176.46 Million | CN¥63.99 Million | CN¥105.52 Million | ▲ +10.4% |
| 2017 | 1.51x | CN¥119.47 Million | CN¥35.77 Million | CN¥78.89 Million | ▲ +274.6% |
| 2016 | 0.40x | CN¥66.31 Million | CN¥29.73 Million | CN¥164.05 Million | — |